Personal cost of hospital admission

Cochrane Lecture 1997. What evidence do we need for evidence based medicine?

Journal of epidemiology and community health·1998

Clinical and economic consequences of patients as producers.

Journal of public health medicine·1995

Dextran-coated superparamagnetic iron oxide, an MR contrast agent for assessing lymph nodes in the head and neck.

AJNR. American journal of neuroradiology·1994

S-100 protein remains a practical marker for melanocytic and other tumours.

Melanoma research·1993

Subglottic plasmacytoma: the use of jet ventilation and contact Nd:YAG laser for tissue diagnosis.

Journal of clinical laser medicine & surgery·1993

Perioperative durvalumab plus fluorouracil, leucovorin, oxaliplatin, and docetaxel for resectable gastric and gastro-oesophageal junction adenocarcinoma (MATTERHORN): final results of overall survival and event-free survival by pathological response in a global, randomised, double-blind, placebo-controlled, multicentre, phase 3 trial.

Lancet (London, England)·2026

Wildfire smoke and health: current evidence, mechanisms, and future challenges.

Lancet (London, England)·2026

Use of the bacterial lysate OM-85 for the primary prevention of wheezing lower respiratory illness in preschool children: a randomised, placebo-controlled trial.

Lancet (London, England)·2026

Wealth redistribution policies to mitigate the impact of development assistance defunding: a retrospective evaluation and forecasting analysis up to 2030.

Lancet (London, England)·2026

Induction and consolidation atezolizumab with stereotactic body radiation therapy versus radiation alone in high-risk, early-stage non-small-cell lung cancer (SWOG/NRG S1914): a multicentre, open-label, superiority, phase 3, randomised controlled trial.

Lancet (London, England)·2026

The changing therapeutic landscape of small-cell lung cancer.

Lancet (London, England)·2026

A study on the efficiency and spatial correlation of health resource allocation in Chinese hospitals.

PloS one·2026

Budget impact analysis for albuterol-budesonide fixed-dose combination in the as needed treatment of adult patients with asthma in Kuwait.

Journal of medical economics·2026

Addressing the failure of economic measures of value-for-money to reflect societal preferences for health and social care.

Journal of health services research & policy·2026

Establishing multiple cost-effectiveness thresholds in Oman: a stakeholder-driven approach.

Health economics review·2026

Fever of unknown origin: cost of illness study.

Open medicine (Warsaw, Poland)·2026

The potential usefulness of health asset valuation to promote health among Korean employees.

Scientific reports·2026

Related Experiment Videos

Personal cost of hospital admission

Related Concept Videos

Cochrane Lecture 1997. What evidence do we need for evidence based medicine?

Clinical and economic consequences of patients as producers.

Dextran-coated superparamagnetic iron oxide, an MR contrast agent for assessing lymph nodes in the head and neck.

S-100 protein remains a practical marker for melanocytic and other tumours.

Subglottic plasmacytoma: the use of jet ventilation and contact Nd:YAG laser for tissue diagnosis.

Wildfire smoke and health: current evidence, mechanisms, and future challenges.

Use of the bacterial lysate OM-85 for the primary prevention of wheezing lower respiratory illness in preschool children: a randomised, placebo-controlled trial.

Wealth redistribution policies to mitigate the impact of development assistance defunding: a retrospective evaluation and forecasting analysis up to 2030.

Induction and consolidation atezolizumab with stereotactic body radiation therapy versus radiation alone in high-risk, early-stage non-small-cell lung cancer (SWOG/NRG S1914): a multicentre, open-label, superiority, phase 3, randomised controlled trial.

The changing therapeutic landscape of small-cell lung cancer.

A study on the efficiency and spatial correlation of health resource allocation in Chinese hospitals.

Budget impact analysis for albuterol-budesonide fixed-dose combination in the as needed treatment of adult patients with asthma in Kuwait.

Addressing the failure of economic measures of value-for-money to reflect societal preferences for health and social care.

Establishing multiple cost-effectiveness thresholds in Oman: a stakeholder-driven approach.

Fever of unknown origin: cost of illness study.

The potential usefulness of health asset valuation to promote health among Korean employees.

Related Experiment Videos

Personal cost of hospital admission

Related Concept Videos

Related Articles